Panacea Innovation Ltd - 15 Aug 2025 SCHEDULE 13D/A Report for Atara Biotherapeutics, Inc. Common Stock (ATRA)

Filing Manager
Panacea Innovation Ltd
Reporting Manager
Panacea Innovation Limited
Security
Atara Biotherapeutics, Inc. Common Stock
Symbol
ATRA
Shares outstanding
8,564,500 shares
Disclosed Ownership
1,712,900 shares
Ownership
20%
Form type
SCHEDULE 13D/A
Filing time
19 Aug 2025, 20:15:03 UTC
Date of event
15 Aug 2025
Previous filing
21 May 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Innovation Limited 20% 1,712,900 0 1,712,900 /s/ James Huang James Huang, Founding Managing Partner 0002010692
Panacea Venture Healthcare Fund II, L.P. 20% 1,405,000 0 1,405,000 By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, By: /s/ James Huang James Huang, Founding Managing Partner 0001869939
Panacea Venture Healthcare Fund II GP Company, Ltd. 20% 1,405,000 0 1,405,000 By: Panacea Innovation Limited, its sole owner, By: /s/ James Huang James Huang, Founding Managing Partner
Panacea Opportunity Fund I, L.P. 4.2% 307,900 0 307,900 By: Panacea Opportunity Fund I GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, By: /s/ James Huang James Huang, Founding Managing Partner 0001869966
Panacea Opportunity Fund I GP Company, Ltd. 4.2% 307,900 0 307,900 By: Panacea Innovation Limited, its sole owner, By: /s/ James Huang James Huang, Founding Managing Partner
James Huang 20% 1,712,900 0 1,712,900 /s/ James Huang James Huang 0001573160